← Back to Patent Explorer
US4331649A Expired / Lapsed US ⏱️ 0.0 years remaining

Immune complex assay

Assignee: Murex Diagnostics Inc
•
Filing: 1979-10-09
•
Granted: 1982-05-25
•
Expires: 1999-10-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Method for the estimation of immune complex and analysis of a constituent thereof. Method comprises a latex particle agglutination test in which a reagent comprising low affinity latex particles is contacted with a sample containing immune complex. The low affinity coated latex particles are latex particles coated with IgG antibodies to the complex constituent and may be prepared by contacting latex particles with the IgG antibodies, the latter optionally being substituted with a coupling agent. One or more reagents are conveniently provided in kit form.

Inventors

  • 👤 Shireen M. Chantler
  • 👤 William Edgar

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-27 12:58
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/564

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 67 words
A method for the estimation of an immune complex and analysis of a constituent thereof comprising a latex particle agglutination test in which a reagent comprising low affinity latex particles is contacted with a sample containing immune complex, the low affinity latex particles comprising latex particles coated with IgG antibodies to the complex constituent in an amount of from 2 to 10 μg per mg of latex.
Claim 2
Independent Claim 67 words
A method for the estimation of an immune complex and analysis of a constituent thereof comprising a latex particle agglutination test in which a reagent comprising low affinity latex particles is contacted with a sample containing immune complex, the low affinity latex particles comprising latex particles coated with IgG antibodies to the complex constituent in an amount of from 2 to 10 μg per mg of latex.
Claim 3
Dependent Claim 15 words
A method according to claim 1 in which the IgG antibodies are of non-human origin.
Claim 4
Dependent Claim 31 words
A method according to either claim 1 or claim 2 wherein the complex constituent is selected from the group consisting of an immunoglobulin constituent, a complement constituent or an antigen constituent.
Claim 5
Dependent Claim 15 words
A method according to claim 1 wherein the agglutination test comprises a slide agglutination test.

References Cited (Backward Citations)

US3088875A Cited
US4118349A Cited
GB1503547A Cited
US4141965A Cited
US4181636A Cited
GB2005275B Cited
GB2004892B Cited
GB2027031A Cited
GB2030293A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-05-24 1985-11-23 1986-05-25 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-05-24 1989-11-23 1990-05-25 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-05-24 1993-11-23 1994-05-25 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag